Table 1.
Clinical details of spinal cord-injured subjects with spasticity
| Spasticity (0–5)a | ||||||
|---|---|---|---|---|---|---|
| Subject | Duration (years) | Level | Severity | Extensor | Flexor | Medicineb |
| SCI-S1 | 4 | T8 | Com | 3 | 4 | Baclofen |
| SCI-S2 | 4 | C5 | Incom | 2 | 3 | Baclofen |
| SCI-S3 | 16 | C5 | Com | 1 | 1 | Baclofen, Diazepam |
| SCI-S4 | 7 | C4–C5 | Incom | 4 | 4 | Baclofen, Clonazepam, Gabapentin |
| SCI-S5 | 6 | C3 | Incom | 3 | 3 | — |
| SCI-S6 | 17 | C7–T6 | Incom | 4 | 4 | Baclofen |
| SCI-S7 | 7 | T11 | Com | 3 | 4 | Gabapentin |
Duration, duration of injury prior to examination; Level, neurological level of injury; T, thoracic and C, cervical vertebrae; Com, complete and Incom, incomplete spinal cord injury. The causes of injury included: falling tree accident, diving accident, traffic accident, ependymoma, and cavernoma.
a
Right knee extensor and flexor spasticity graded with the modified Ashworth scale as a clinical assessment of function.
b
Medicine relevant only to SCI and spasticity is listed.